Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · FRIENDSWOOD, TX · NPI 1730375502
Verified facts
CMS Open Payments records show Jennifer C Lee, M.D. received $32.98 in general payments during 2025 across 1 reported records.
ADC THERAPEUTICS AMERICA, INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ADC THERAPEUTICS AMERICA, INC. | Unresolved — no canonical attribution shown | $32.98 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZYNLONTA Normalized: zynlonta |
Drug | ADC THERAPEUTICS AMERICA, INC. | $32.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 567 | 232 |
| Levothyroxine Sodium | Levothyroxine Sodium | 429 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 384 | 149 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 304 | 87 |
| Losartan Potassium | Losartan Potassium | 274 | 106 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 233 | 109 |
| Lisinopril | Lisinopril | 219 | 95 |
| Fluticasone Propionate | Fluticasone Propionate | 203 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 191 | 60 |
| Famotidine | Famotidine | 161 | 61 |
| Simvastatin | Simvastatin | 155 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 146 | 52 |
| Gabapentin | Gabapentin | 139 | 67 |
| Ibuprofen | Ibuprofen | 139 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 121 | 46 |
| Trazodone Hcl | Trazodone Hcl | 121 | 39 |
| Alvesco | Ciclesonide | 109 | 46 |
| Atenolol | Atenolol | 107 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 28 |
| Metformin Hcl Er | Metformin Hcl | 96 | 37 |
| Omeprazole | Omeprazole | 94 | 42 |
| Furosemide | Furosemide | 91 | 40 |
| Tramadol Hcl | Tramadol Hcl | 90 | 25 |
| Azelastine Hcl | Azelastine Hcl | 88 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 88 | 34 |
| Montelukast Sodium | Montelukast Sodium | 85 | 33 |
| Alendronate Sodium | Alendronate Sodium | 83 | 37 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 81 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 77 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 70 | 30 |
| Glipizide | Glipizide | 66 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 65 | 26 |
| Lovastatin | Lovastatin | 63 | 21 |
| Metformin Hcl | Metformin Hcl | 63 | 28 |
| Sertraline Hcl | Sertraline Hcl | 62 | 21 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 60 | 18 |
| Meloxicam | Meloxicam | 57 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 20 |
| Acyclovir | Acyclovir | 54 | 18 |
| Baclofen | Baclofen | 54 | 15 |
| Carvedilol | Carvedilol | 51 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 51 | 12 |
| Allopurinol | Allopurinol | 47 | 24 |
| Ondansetron Odt | Ondansetron | 47 | 19 |
| Sumatriptan Succinate | Sumatriptan Succinate | 47 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 18 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 46 | 35 |
| Clonazepam | Clonazepam | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 26 |
| Nystatin | Nystatin | 42 | 18 |
| Potassium Chloride | Potassium Chloride | 41 | 21 |
| Hydrocortisone | Hydrocortisone | 38 | 19 |
| Prednisone | Prednisone | 38 | 29 |
| Temazepam | Temazepam | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 36 | 12 |
| Pradaxa | Dabigatran Etexilate Mesylate | 35 | 17 |
| Clonidine Hcl | Clonidine Hcl | 34 | suppressed |
| Ozempic | Semaglutide | 34 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 34 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 34 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 33 | 12 |
| Warfarin Sodium | Warfarin Sodium | 33 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 32 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 29 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 28 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 28 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 27 | suppressed |
| Jardiance | Empagliflozin | 27 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 15 |
| Cefadroxil | Cefadroxil | 25 | 20 |
| Naproxen | Naproxen | 24 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 20 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 22 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Metronidazole | Metronidazole | 22 | 11 |
| Mirtazapine | Mirtazapine | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | 12 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Eliquis | Apixaban | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 16 | 16 |
| Azithromycin | Azithromycin | 16 | 15 |
| Ciclopirox | Ciclopirox | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Lorazepam | Lorazepam | 16 | 15 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Asmanex Hfa | Mometasone Furoate | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 13 | suppressed |
| Ibu | Ibuprofen | 13 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 12 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Spironolactone | Spironolactone | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.98 · 1 records | ADC THERAPEUTICS AMERICA, INC. | ZYNLONTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error